INSPIRE DUCHENNE Update & Expansion

Updates from the INSPIRE DUCHENNE clinical trial of SGT-003, SolidBio’s investigational, next-generation AAV microdystrophin gene therapy candidate brings expanded eligibility criteria, additional trial sites in more regions, and upcoming preliminary data.

Both the Community Letter and the recent Press Release cover these updates, providing valuable context. Please feel free to share these resources with others in your network.

READ THE FULL PRESS RELEASE HERE

LETTER TO THE COMMUNITY HERE